Table 2.

The overall and site-specific percent test positive and prevalence of CIN grade 2 or more severe diagnosis (CIN2+) and grade III or more severe diagnosis (CIN3+)

Percent test positive
careHPVHybrid capture 2Prevalence
HPV E6 (HPV16/18/45)ClinicianSelfClinicianSelfVIACIN2+CIN3+
Overall (n = 7,421)1.814.414.514.517.97.31.91.3
By site
 Yangcheng (n = 3,180)1.513.614.514.317.76.21.71.0
 Xinmi (n = 2,463)1.912.914.013.417.35.41.51.3
 Tonggu (n = 1,778)2.017.815.116.419.111.93.01.9
Pa0.4<0.0010.60.020.3<0.0010.0010.029
  • aPearson χ2 test.